Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibody levels in COVID-19 patients (COVERT)
NCT06862531Completed
- Sponsor
- BIOASTER
- Start
- Sep 2020
- Primary completion
- Nov 2020
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by BIOASTER. Primary endpoint: Correlation between serum antibody levels (IgM/IgG), disease stage, and disease severity at 10 months. Started Sep 2020; status: completed.
Beyond the preview
Go deeper on NCT06862531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06862531.